Clinical Trials Directory

Trials / Unknown

UnknownNCT01448746

Optimal Prophylactic Method of Venous Thromboembolism (VTE)

Optimal Prophylactic Method of Venous Thromboembolism for Gastrectomy in Korean Patients

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
682 (actual)
Sponsor
The Catholic University of Korea · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is to define the optimal method of prophylaxis for patients with gastrectomy in Korea and the investigators hypothesized only mechanical method would be enough for preventing VTE on perioperative period.

Detailed description

Venous thromboembolism (VTE) is common and often fatal complication in patients with cancer. Gastric cancer is the most frequent cancer in Korea. The incidence of VTE would be increased in patients with gastric cancer, especially associated surgery. However, the incidence and optimal prophylactic method associated with cancer surgery are not well studied in Asian patients. Most Korean surgeon concerns regarding the increased postoperative bleeding associated with low molecular weight heparin(LMWH)prophylaxis. The incidence and adverse event will be examined to define the optimal prophylactic method of VTE in surgical patients with gastric cancer.

Conditions

Interventions

TypeNameDescription
DRUGlow molecular weight heparin40mg 12 hours before surgery and 12 hours later surgery

Timeline

Start date
2011-10-01
Primary completion
2016-01-01
Completion
2017-08-01
First posted
2011-10-07
Last updated
2017-02-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01448746. Inclusion in this directory is not an endorsement.